EP3445388
MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES
:
EP einkaleyfi í gildi á Íslandi:
18.4.2017:
17.4.2024:
17727373.7
:
27.5.2024:
15.6.2024
:
17.4.2037:
17.4.2026:
30.4.2026
:
MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES
18.4.2017
17.4.2024
27.5.2024
15.6.2024
17.4.2026
:
Vertex Pharmaceuticals Incorporated:
50 Northern Avenue, Boston, MA 02210, US
:
COWAN, Chad, Albert:
Cambridge, MA 02139, US
:
LUNDBERG, Ante, Sven:
Cambridge, MA 02139, US
:
CHAKRABORTY, Tirtha:
Cambridge, MA 02139, US
:
LIN, Michelle, I-ching:
Cambridge, MA 02139, US
:
MISHRA, Bibhu, Prasad:
Cambridge, MA 02139, US
:
PAIK, Elizabeth, Jae-eun:
Cambridge, MA 02139, US
:
KERNYTSKY, Andrew:
Cambridge, MA 02139, US
:
BORLAND, Todd, Douglass:
Cambridge, MA 02139, US
:
201662324024 P:
18.4.2016:
US
:
201662382522 P:
1.9.2016:
US
:
201662429428 P:
2.12.2016:
US
:
IB2017000577:
18.4.2017
:
A61K 38/46, C12N 9/22, C12N 15/10, C12N 15/113
: 8
: 17.5.2024
: 17.4.2025
: Árnason Faktor ehf.
: 9
: 14.4.2025
: 17.4.2026
: Árnason Faktor ehf.